Immunoaffinity Chromatography Market size is set to expand at significant growth rate during the forecast period i.e., between 2024-2036.
This can primarily be attributed to the increasing application of immunoaffinity chromatography in genetic engineering and molecular research. Additionally, immunoaffinity chromatography-based techniques are highly powerful protein purification and isolation techniques, which further makes them suitable for a wide range of applications, including clinical diagnostics to environmental monitoring. Over the past few years, immunoaffinity chromatography has been used extensively for the purification of the protein, which further helps in the detection of various diseases including, liver diseases, infectious diseases, and others.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
Regional Scope |
|
The immunoaffinity chromatography market is segmented by product type into reagents & consumables, and instruments. Reagents & consumables are further sub-segmented into protein extract, buffers, columns, centrifuge tubes, and others, while the instruments are divided into centrifuge, rotator, incubator, and others. The reagents & consumables segment is anticipated to capture a larger share of the market owing to the rising demand for immunoaffinity chromatography in immunotherapy procedures that utilizes antibodies for treatment. Based on application, the market has been divided into genetic engineering, drug development, metabolic research, and others. Over the past couple of years, the application of immunoaffinity chromatography has increased significantly in the development of advanced immunotherapeutic procedures for treating cancer. As immunotherapies are becoming widely accepted for cancer treatment, the demand for immunoaffinity chromatography procedures is expected to surge over the forecast period.
Our in-depth analysis of the global immunoaffinity chromatography market includes the following segments:
|
By Product |
|
|
By Application |
|
|
By End-User |
|
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. Presently, the immunoaffinity chromatography market in North America industry is poised to hold largest revenue share by 2036, on account of extensive R&D activities for the development of cancer drugs and biologics. Since the prevalence of cancer has increased in the region, there have been high investments in research and development by life sciences companies for the development of better-performing drugs. This is also a key factor contributing to the market’s growth in the region. According to the WHO, more than 2.2 million new cancer cases were recorded in the United States in 2020. Out of the total cancer cases, the prevalence of breast, lung, and prostate cancer was relatively high compared to other cancer forms, accounting for approximately 11.1%, 10%, and 9.2%, respectively. Asia-Pacific is anticipated to be the fastest-growing region on account of the improving economic conditions in countries such as India, China, Malaysia, and others accompanied by growing healthcare expenditure. Besides, the increasing cancer research & development activities in the region are also projected to create a surge in demand for immunoaffinity chromatography. Asia-Pacific region holds an estimated 50% of the world's new cancer cases annually.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?